Yukuhashi, Japan

Yumi Ogami

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yumi Ogami: Innovator in Cancer Treatment Technologies

Introduction

Yumi Ogami is a prominent inventor based in Yukuhashi, Japan. She has made significant contributions to the field of cancer treatment through her innovative patents. With a total of 3 patents, her work focuses on enhancing the efficacy and safety of cancer therapies.

Latest Patents

One of her latest patents is an "Ultrasonic cancer treatment enhancer and cell killer." This invention provides a method to significantly improve the effects of cancer treatment through ultrasonic irradiation while ensuring a high level of safety. The device comprises metal semiconductor particles that can be activated upon ultrasonic irradiation to effectively kill or destruct cancer cells. Another notable patent is the "Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation." This invention features a titanium dioxide composite that can be stably dispersed in an aqueous solvent, allowing for easy administration into a living body. It enables the elimination of the drug efficacy of a pharmaceutical compound by utilizing light irradiation, thereby reducing adverse drug reactions.

Career Highlights

Yumi Ogami is currently associated with Toto Ltd., where she continues to develop her groundbreaking technologies. Her work has garnered attention for its potential to revolutionize cancer treatment methodologies.

Collaborations

Yumi collaborates with notable colleagues, including Koki Kanehira and Shuji Sonezaki, who contribute to her innovative projects.

Conclusion

Yumi Ogami's contributions to cancer treatment technologies highlight her role as a leading inventor in the field. Her innovative patents demonstrate a commitment to improving patient outcomes through advanced therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…